FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Massimo Di Nicola

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Concepts & Ideas

Treatment Outcome

Disorders

Co-author Network

Publications

TOP 3
Anna Guidetti; Rodolfo Lanocita; Silvia L Locatelli; Walter Malorni; Alfonso Marchianò; Paola Matteucci; Roberta Mortarini; Marina Pierdominici; Corrado Tarella; Andrea Anichini; Cristiana Barbati; Carmelo Carlo-Stella; Paolo Corradini; Lilli Devizzi; Massimo Di Nicola; Anna Dodero; Lucia Farina; Alessandro M Gianni
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Anna Guidetti; Silvia L Locatelli; Luigi Mariani; Rosalba Miceli; Roberto Passera; Alessandra Risso; Marco Ruella; Corrado Tarella; Adele Testi; stefano buttiglieri; Carmelo Carlo-Stella; liliana devizzi; Massimo Di Nicola; Arianna Giacomini; Alessandro M Gianni
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Roberta Zappasodi; Italia Bongarzone; Antonello Cabras; Carmelo Carlo-Stella; Lorenzo Castagnoli; Gaia C Ghedini; Alessandro M Gianni; Michele Magni; Antonella Messina; Serenella M Pupa; Monica Tortoreto; Claudio Tripodo; Massimo Di Nicola
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Massimo Di Nicola (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Anna Guidetti; Rodolfo Lanocita; Silvia L Locatelli; Walter Malorni; Alfonso Marchianò; Paola Matteucci; Roberta Mortarini; Marina Pierdominici; Corrado Tarella; Andrea Anichini; Cristiana Barbati; Carmelo Carlo-Stella; Paolo Corradini; Lilli Devizzi; Massimo Di Nicola; Anna Dodero; Lucia Farina; Alessandro M Gianni
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
British journal of haematology 2012;158(1):108-19.
2011: Anna Guidetti; Silvia L Locatelli; Luigi Mariani; Rosalba Miceli; Roberto Passera; Alessandra Risso; Marco Ruella; Corrado Tarella; Adele Testi; stefano buttiglieri; Carmelo Carlo-Stella; liliana devizzi; Massimo Di Nicola; Arianna Giacomini; Alessandro M Gianni
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Cancer 2011;117(22):5074-84.
2011: Roberta Zappasodi; Italia Bongarzone; Antonello Cabras; Carmelo Carlo-Stella; Lorenzo Castagnoli; Gaia C Ghedini; Alessandro M Gianni; Michele Magni; Antonella Messina; Serenella M Pupa; Monica Tortoreto; Claudio Tripodo; Massimo Di Nicola
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.
Blood 2011;118(16):4421-30.
2010: Simonetta Viviani; Massimo Di Nicola; Valeria Bonfante; Antonio Di Stasi; Carmelo Carlo-Stella; Paola Matteucci; Michele Magni; liliana devizzi; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.
Leukemia & lymphoma 2010;51(7):1251-9.
2010: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; liliana devizzi; Anna Guidetti; Paola Matteucci; ALESSANDRO MASSIMO GIANNI
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma: long-term follow-up.
Bone marrow transplantation 2010;45(6):1119-20.
2010: Cristiana Lavazza; Carmelo Carlo-Stella; Arianna Giacomini; Loredana Cleris; Marco Righi; Daniela Sia; Massimo Di Nicola; Michele Magni; Paolo Longoni; Marco Milanesi; Maura Francolini; Annunziata Gloghini; Antonino Carbone; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.
Blood 2010;115(11):2231-40.
2009: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; liliana devizzi; Corrado Tarella; Fabio Benedetti; Maurizio Martelli; Caterina Patti; Guido Parvis; Alessandro Rambaldi; T Barbui; ALESSANDRO MASSIMO GIANNI
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
Bone marrow transplantation 2009;43(6):509-11.
2009: Massimo Di Nicola; Roberta Zappasodi; Carmelo Carlo-Stella; Roberta Mortarini; Serenella M Pupa; Michele Magni; liliana devizzi; Paola Matteucci; Paola Baldassari; Fernando Ravagnani; Antonello Cabras; Andrea Anichini; ALESSANDRO MASSIMO GIANNI
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Blood 2009;113(1):18-27.
2007: Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Roberta Calvi; Alessandra Pescarollo; Valerio Zoli; A Fornari; Domenico Novero; Antonello Cabras; M Stella; A Comino; Daniele Remotti; Maurilio Ponzoni; Daniele Caracciolo; marco ladetto; Michele Magni; liliana devizzi; Rosalba Rosato; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvatore Mirto; ALESSANDRO MASSIMO GIANNI
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
Leukemia 2007;21(8):1802-11.
2007: Cristiana Lavazza; Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Marco Milanesi; Michele Magni; ALESSANDRO MASSIMO GIANNI
Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.
Experimental hematology 2007;35(6):888-97.
2007: Carmelo Carlo-Stella; Anna Guidetti; Massimo Di Nicola; Cristiana Lavazza; Loredana Cleris; Daniela Sia; Paolo Longoni; Marco Milanesi; Michele Magni; Zoltan Nagy; Paolo Corradini; Antonino Carbone; Franca Formelli; ALESSANDRO MASSIMO GIANNI
IFN-gamma enhances the antimyeloma activity of the fully human anti-human leukocyte antigen-DR monoclonal antibody 1D09C3.
Cancer research 2007;67(7):3269-75.
2007: Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Loredana Cleris; Cristiana Lavazza; Raffaella Milani; Marco Milanesi; Michele Magni; Virgilio Pace; Francesco Colotta; Maria A Avanzini; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.
Stem cells (Dayton, Ohio) 2007;25(1):252-61.
2006: Vittorio Perfetti; Salvatore Siena; Giovanni Palladini; Marco Bregni; Massimo Di Nicola; Laura Obici; Michele Magni; Laura Brunetti; ALESSANDRO MASSIMO GIANNI; Giampaolo Merlini
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Haematologica 2006;91(12):1635-43.
2006: Carmelo Carlo-Stella; Cristiana Lavazza; Massimo Di Nicola; Loredana Cleris; Paolo Longoni; Marco Milanesi; Michele Magni; Daniele Morelli; Annunziata Gloghini; Antonino Carbone; ALESSANDRO MASSIMO GIANNI
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Human gene therapy 2006;17(12):1225-40.
2006: Carmelo Carlo-Stella; Anna Guidetti; Massimo Di Nicola; Paolo Longoni; Loredana Cleris; Cristiana Lavazza; Marco Milanesi; Raffaella Milani; Matteo Carrabba; Lucia Farina; Franca Formelli; ALESSANDRO MASSIMO GIANNI; Paolo Corradini
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Experimental hematology 2006;34(6):721-7.
2006: Paola Matteucci; Carmelo Carlo-Stella; Massimo Di Nicola; Michele Magni; Anna Guidetti; Maddalena Marchesi; ALESSANDRO MASSIMO GIANNI
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Haematologica 2006;91(2):255-7.
2006: Carmelo Carlo-Stella; Massimo Di Nicola; Maria Caterina Turco; Loredana Cleris; Cristiana Lavazza; Paolo Longoni; Marco Milanesi; Michele Magni; Massimo Ammirante; Arturo Leone; Zoltan Nagy; Walter R Gioffrè; Franca Formelli; ALESSANDRO MASSIMO GIANNI
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Cancer research 2006;66(3):1799-808.
2006: Andrea Anichini; Roberta Mortarini; Luca Romagnoli; Paola Baldassari; Antonello Cabras; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI; Massimo Di Nicola
Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.
Blood 2006;107(2):602-9.
2004: Massimo Di Nicola; Carmelo Carlo-Stella; Jacopo Mariotti; liliana devizzi; maura massimino; Antonello Cabras; Michele Magni; Paola Matteucci; Anna Guidetti; Lorenza Gandola; ALESSANDRO MASSIMO GIANNI
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
British journal of haematology 2004;126(6):815-20.
2004: Massimo Di Nicola; Carmelo Carlo-Stella; Roberta Mortarini; Paola Baldassari; Anna Guidetti; Gianfrancesco Gallino; Michele Del Vecchio; Fernando Ravagnani; Michele Magni; Paul Chaplin; Natale Cascinelli; Giorgio Parmiani; ALESSANDRO MASSIMO GIANNI; Andrea Anichini
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5381-90.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Raffaella Milani; Anna Guidetti; Michele Magni; Marco Milanesi; Paolo Longoni; Paola Matteucci; Franca Formelli; Fernando Ravagnani; Paolo Corradini; ALESSANDRO MASSIMO GIANNI
Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD34+ cells in poor mobilizers.
Blood 2004;103(9):3287-95.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Raffaella Milani; Paolo Longoni; Marco Milanesi; Carlo Bifulco; Claudio Stucchi; Anna Guidetti; Loredana Cleris; Franca Formelli; Gianni Garotta; ALESSANDRO MASSIMO GIANNI
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.
Experimental hematology 2004;32(2):171-8.
2004: Carmelo Carlo-Stella; Massimo Di Nicola; Paolo Longoni; Raffaella Milani; Marco Milanesi; Anna Guidetti; Krista G Haanstra; margreet jonker; Loredana Cleris; Michele Magni; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factor.
Experimental hematology 2004;32(1):68-75.
2003: Massimo Di Nicola; Sara Napoli; Andrea Anichini; Roberta Mortarini; Luca Romagnoli; Michele Magni; Paola Matteucci; Paola Baldassarri; Ilaria Bersani; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.
Haematologica 2003;88(12):1396-404.
2003: Massimo Di Nicola; Carmelo Carlo-Stella; Andrea Anichini; Roberta Mortarini; Anna Guidetti; Gabrina Tragni; Francesco Gallino; Michele Del Vecchio; Fernando Ravagnani; Daniele Morelli; Paul Chaplin; Nathaly Arndtz; Gerd Sutter; Ingo Drexler; Giorgio Parmiani; Natale Cascinelli; ALESSANDRO MASSIMO GIANNI
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Human gene therapy 2003;14(14):1347-60.
2003: Alessandra Cuttica; Francesco Zallio; marco ladetto; Massimo Di Nicola; Daniele Caracciolo; Michele Magni; Carlo Marinone; Maria Dell'Aquila; Michela Rosace; Alessandro Pileri; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Cancer 2003;98(5):983-92.
2003: ALESSANDRO MASSIMO GIANNI; Michele Magni; Maurizio Martelli; Massimo Di Nicola; Carmelo Carlo-Stella; Silvana Pilotti; Alessandro Rambaldi; Sergio Cortelazzo; Caterina Patti; Guido Parvis; Fabio Benedetti; Saveria Capria; Paolo Corradini; Corrado Tarella; Tiziano Barbui
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).
Blood 2003;102(2):749-55.
2003: Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di Nicola; Sergio Cortelazzo; Rosalba Rosato; Carlo Rosanelli; Nicola Di Renzo; Maurizio Musso; Enzo Pavone; Gino Santini; Alessandra Pescarollo; Alberto De Crescenzo; Massimo Federico; Andrea Gallamini; Patrizia Pregno; Roberta Romano; Paolo Coser; Eugenio Gallo; Mario Boccadoro; Tiziano Barbui; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Alessandro Levis
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
Cancer 2003;97(11):2748-59.
2002: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; Cristiana Lavazza; Salvatore Grisanti; Carlo Bifulco; Silvana Pilotti; Daniela Papini; Juan Rosai; ALESSANDRO MASSIMO GIANNI
Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.
Leukemia research 2002;26(12):1131-3.
2002: Corrado Tarella; Massimo Di Nicola; Daniele Caracciolo; Francesco Zallio; Alessandra Cuttica; Paola Omedè; P Bondesan; Michele Magni; Paola Matteucci; Andrea Gallamini; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Bone marrow transplantation 2002;30(11):725-32.
2002: Carmelo Carlo-Stella; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI
[Mesenchymal stem cells: biology and clinical applications].
Tumori 2002;88(6):A4-7.
2002: Carmelo Carlo-Stella; Massimo Di Nicola; Michele Magni; Paolo Longoni; Marco Milanesi; Claudio Stucchi; Loredana Cleris; Franca Formelli; ALESSANDRO MASSIMO GIANNI
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
Cancer research 2002;62(21):6152-7.
2002: Paola Matteucci; Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Caterina Uberti; ALESSANDRO MASSIMO GIANNI
Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody.
Blood 2002;100(3):1104-5.
2002: Massimo Di Nicola; Carmelo Carlo-Stella; Michele Magni; Marco Milanesi; Paolo Longoni; Paola Matteucci; Salvatore Grisanti; ALESSANDRO MASSIMO GIANNI
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.
Blood 2002;99(10):3838-43.
2001: Sergio Cortelazzo; Alessandro Rambaldi; Andrea Rossi; Elena Oldani; M Ghielmini; F Benedetti; Corrado Tarella; F Zaglio; Umberto Vitolo; Massimo Di Nicola; Enrico Pogliani; Franco Cavalli; ALESSANDRO MASSIMO GIANNI; Tiziano Barbui
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
British journal of haematology 2001;114(2):333-41.
2001: Valeria Bonfante; Simonetta Viviani; liliana devizzi; Anna Di Russo; Massimo Di Nicola; Michele Magni; Paola Matteucci; Salvatore Grisanti; Pinuccia Valagussa; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2000: Massimo Di Nicola; Carmelo Carlo-Stella; Marco Milanesi; Michele Magni; Paolo Longoni; Roberta Mortarini; Andrea Anichini; Rosella Tomanin; MAURIZIO SCARPA; ALESSANDRO MASSIMO GIANNI
Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex.
British journal of haematology 2000;111(1):344-50.
2000: Michele Magni; Massimo Di Nicola; liliana devizzi; Paola Matteucci; F Lombardi; Lorenza Gandola; Fernando Ravagnani; Roberto Giardini; G Dastoli; Corrado Tarella; Alessandro Pileri; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Blood 2000;96(3):864-9.
1999: Andrea Anichini; Alessandra Molla; Roberta Mortarini; Gabrina Tragni; Ilaria Bersani; Massimo Di Nicola; ALESSANDRO MASSIMO GIANNI; Silvana Pilotti; R Dunbar; V Cerundolo; Giorgio Parmiani
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
The Journal of experimental medicine 1999;190(5):651-67.
1999: Massimo Di Nicola; Marco Milanesi; Michele Magni; Marco Bregni; Carmelo Carlo-Stella; Paolo Longoni; Rosella Tomanin; Fernando Ravagnani; MAURIZIO SCARPA; Craig T Jordan; ALESSANDRO MASSIMO GIANNI
Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes.
Human gene therapy 1999;10(11):1875-84.
1999: Massimo Di Nicola; Paolo Longoni; Michele Magni; ALESSANDRO MASSIMO GIANNI
The influence of interleukin (IL)-4 and IL-13 on human dendritic cell differentiation from CD34+ progenitor cells: the importance of the source of serum.
Experimental hematology 1999;27(2):386-7.
1999: Fernando Ravagnani; Salvatore Siena; S De Reys; Massimo Di Nicola; Paola Notti; Roberto Giardini; Marco Bregni; Paola Matteucci; ALESSANDRO MASSIMO GIANNI; G Pellegris
Improved collection of mobilized CD34+ hematopoietic progenitor cells by a novel automated leukapheresis system.
Transfusion 1999;39(1):48-55.
1998: Massimo Di Nicola; Andrea Anichini; Roberta Mortarini; Marco Bregni; G Parmiani; ALESSANDRO MASSIMO GIANNI
Human dendritic cells: natural adjuvants in antitumor immunotherapy.
Cytokines, cellular & molecular therapy 1998;4(4):265-73.
1998: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Paolo Longoni; Michele Magni; Marco Milanesi; Paola Matteucci; Roberta Mortarini; Andrea Anichini; Giorgio Parmiani; Ingo Drexler; Volker Erfle; Gerd Sutter; ALESSANDRO MASSIMO GIANNI
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.
Cancer gene therapy 1998;5(6):350-6.
1998: Arturo Chiti; Massimo Di Nicola; A Spinelli; Salvatore Siena; Marco Bregni; Giordano Savelli; ALESSANDRO MASSIMO GIANNI; Emilio Bombardieri
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: clinical usefulness of [99mTc]- sestamibi.
Tumori 1998;84(5):612-3.
1998: Marco Bregni; S Shammah; F Malaffo; Massimo Di Nicola; Marco Milanesi; Michele Magni; Paola Matteucci; Fernando Ravagnani; Craig T Jordan; Salvatore Siena; ALESSANDRO MASSIMO GIANNI
Adenovirus vectors for gene transduction into mobilized blood CD34+ cells.
Gene therapy 1998;5(4):465-72.
1998: Marco Bregni; Massimo Di Nicola; Salvatore Siena; N Belli; Marco Milanesi; S Shammah; Fernando Ravagnani; ALESSANDRO MASSIMO GIANNI
Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cells.
Haematologica 1998;83(3):204-8.
1997: Roberta Mortarini; Andrea Anichini; Massimo Di Nicola; Salvatore Siena; Marco Bregni; F Belli; Alessandra Molla; ALESSANDRO MASSIMO GIANNI; G Parmiani
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.
Cancer research 1997;57(24):5534-41.
1997: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; C Brambilla; Massimo Di Nicola; F Lombardi; Lorenza Gandola; Corrado Tarella; Alessandro Pileri; Fernando Ravagnani; Pinuccia Valagussa; Gianni Bonadonna
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1996: Massimo Di Nicola; Salvatore Siena; Paolo Corradini; Marco Bregni; Marco Milanesi; Michele Magni; P A Ruffini; Fernando Ravagnani; Corrado Tarella; ALESSANDRO MASSIMO GIANNI
Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
Bone marrow transplantation 1996;18(6):1117-21.
1996: Massimo Di Nicola; Salvatore Siena; Marco Bregni; N Belli; Marco Milanesi; P A Ruffini; F Malaffo; Fernando Ravagnani; ALESSANDRO MASSIMO GIANNI
Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substitute.
Bone marrow transplantation 1996;18(3):619-23.
1996: Massimo Di Nicola; Marco Bregni; Salvatore Siena; P A Ruffini; Marco Milanesi; Fernando Ravagnani; ALESSANDRO MASSIMO GIANNI
Combined negative and positive selection of mobilized CD34 blood cells.
British journal of haematology 1996;94(4):716-21.
1996: Salvatore Siena; Marco Bregni; Massimo Di Nicola; Michele Magni; Fernando Ravagnani; L Gandola; F Lombardi; ALESSANDRO MASSIMO GIANNI
[Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation].
Tumori 1996;82(2 Suppl):S23-7.
1996: Marco Bregni; Salvatore Siena; Massimo Di Nicola; A Dodero; Fedro Alessandro Peccatori; Fernando Ravagnani; G Danesini; A Laffranchi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):628-35.
1995: Salvatore Siena; Massimo Di Nicola; Marco Bregni; Roberta Mortarini; Andrea Anichini; L Lombardi; Fernando Ravagnani; G Parmiani; ALESSANDRO MASSIMO GIANNI
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.
Experimental hematology 1995;23(14):1463-71.
1994: Salvatore Siena; Marco Bregni; Massimo Di Nicola; F Ravagani; Fedro Alessandro Peccatori; L Gandola; F Lombardi; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(10):935-41.
1994: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fernando Ravagnani; F Vitello; N Belli; A Dodero; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.
Bone marrow transplantation 1994;14(6):863-9.
1993: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; L Zorzino; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
The International journal of artificial organs 1993;16 Suppl 5():80-2.
1993: Fernando Ravagnani; Paola Notti; Salvatore Siena; Marco Bregni; L Zorzino; Massimo Di Nicola; N Belli; ALESSANDRO MASSIMO GIANNI; G Pellegris
Clinical application of growth factors for collection of circulating hematopoietic progenitors in breast cancer patients treated with high-dose cyclophosphamide.
The International journal of artificial organs 1993;16 Suppl 5():35-8.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Massimo Di Nicola; Michele Magni; Fedro Alessandro Peccatori; P Valagussa; Gianni Bonadonna
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):889-91.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; Massimo Di Nicola; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; I Sklenar; Gianni Bonadonna
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):759-66.
1993: Salvatore Siena; Marco Bregni; Laura Bonsi; Pierluigi Strippoli; Fedro Alessandro Peccatori; Michele Magni; Massimo Di Nicola; Gian Paolo Bagnara; A Massimo Gianni
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s).
Stem cells (Dayton, Ohio) 1993;11 Suppl 2():72-5.
1992: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; Michele Magni; Massimo Di Nicola; F Lombardi; Corrado Tarella; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1955-62.
1992: Marco Bregni; Michele Magni; Salvatore Siena; Massimo Di Nicola; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.
Blood 1992;80(6):1418-22.